SPARC inhibits metabolic plasticity in ovarian cancer

Christine Naczki, Bincy John, Chirayu Patel, Ashlyn Lafferty, Alia Ghoneum, Hesham Afify, Michael A White, Amanda Davis, Guangxu Jin, Steven Kridel, Neveen Said

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The tropism of ovarian cancer (OvCa) to the peritoneal cavity is implicated in widespread dissemination, suboptimal surgery, and poor prognosis. This tropism is influenced by stromal factors that are not only critical for the oncogenic and metastatic cascades, but also in the modulation of cancer cell metabolic plasticity to fulfill their high energy demands. In this respect, we investigated the role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in metabolic plasticity of OvCa. We used a syngeneic model of OvCa in Sparc-deficient and proficient mice to gain comprehensive insight into the paracrine effect of stromal-SPARC in metabolic programming of OvCa in the peritoneal milieu. Metabolomic and transcriptomic profiling of micro-dissected syngeneic peritoneal tumors revealed that the absence of stromal-Sparc led to significant upregulation of the enzymes involved in glycolysis, TCA cycle, and mitochondrial electron transport chain (ETC), and their metabolic intermediates. Absence of stromal-Sparc increased reactive oxygen species and perturbed redox homeostasis. Recombinant SPARC exerted a dose-dependent inhibitory effect on glycolysis, mitochondrial respiration, ATP production and ROS generation. Comparative analysis with human tumors revealed that SPARC-regulated ETC-signature inversely correlated with SPARC transcripts. Targeting mitochondrial ETC by phenformin treatment of tumor-bearing Sparc-deficient and proficient mice mitigated the effect of SPARC-deficiency and significantly reduced tumor burden, ROS, and oxidative tissue damage in syngeneic tumors. In summary, our findings provide novel insights into the role of SPARC in regulating metabolic plasticity and bioenergetics in OvCa, and shines light on its potential therapeutic efficacy.

Original languageEnglish (US)
Article number385
JournalCancers
Volume10
Issue number10
DOIs
StatePublished - Oct 16 2018
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Cysteine
Electron Transport
Proteins
Tropism
Glycolysis
Neoplasms
Phenformin
Metabolomics
Peritoneal Cavity
Tumor Burden
Recombinant Proteins
Energy Metabolism
Oxidation-Reduction
Reactive Oxygen Species
Respiration
Homeostasis
Up-Regulation
Adenosine Triphosphate
Enzymes

Keywords

  • Glycolysis
  • Metabolic plasticity
  • Ovarian cancer
  • OXPHOS
  • Peritoneal metastasis
  • Redox homeostasis
  • SPARC
  • Syngeneic model

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Naczki, C., John, B., Patel, C., Lafferty, A., Ghoneum, A., Afify, H., ... Said, N. (2018). SPARC inhibits metabolic plasticity in ovarian cancer. Cancers, 10(10), [385]. https://doi.org/10.3390/cancers10100385

SPARC inhibits metabolic plasticity in ovarian cancer. / Naczki, Christine; John, Bincy; Patel, Chirayu; Lafferty, Ashlyn; Ghoneum, Alia; Afify, Hesham; White, Michael A; Davis, Amanda; Jin, Guangxu; Kridel, Steven; Said, Neveen.

In: Cancers, Vol. 10, No. 10, 385, 16.10.2018.

Research output: Contribution to journalArticle

Naczki, C, John, B, Patel, C, Lafferty, A, Ghoneum, A, Afify, H, White, MA, Davis, A, Jin, G, Kridel, S & Said, N 2018, 'SPARC inhibits metabolic plasticity in ovarian cancer', Cancers, vol. 10, no. 10, 385. https://doi.org/10.3390/cancers10100385
Naczki C, John B, Patel C, Lafferty A, Ghoneum A, Afify H et al. SPARC inhibits metabolic plasticity in ovarian cancer. Cancers. 2018 Oct 16;10(10). 385. https://doi.org/10.3390/cancers10100385
Naczki, Christine ; John, Bincy ; Patel, Chirayu ; Lafferty, Ashlyn ; Ghoneum, Alia ; Afify, Hesham ; White, Michael A ; Davis, Amanda ; Jin, Guangxu ; Kridel, Steven ; Said, Neveen. / SPARC inhibits metabolic plasticity in ovarian cancer. In: Cancers. 2018 ; Vol. 10, No. 10.
@article{0f5dcae746774d53be8bef9b2d9adf05,
title = "SPARC inhibits metabolic plasticity in ovarian cancer",
abstract = "The tropism of ovarian cancer (OvCa) to the peritoneal cavity is implicated in widespread dissemination, suboptimal surgery, and poor prognosis. This tropism is influenced by stromal factors that are not only critical for the oncogenic and metastatic cascades, but also in the modulation of cancer cell metabolic plasticity to fulfill their high energy demands. In this respect, we investigated the role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in metabolic plasticity of OvCa. We used a syngeneic model of OvCa in Sparc-deficient and proficient mice to gain comprehensive insight into the paracrine effect of stromal-SPARC in metabolic programming of OvCa in the peritoneal milieu. Metabolomic and transcriptomic profiling of micro-dissected syngeneic peritoneal tumors revealed that the absence of stromal-Sparc led to significant upregulation of the enzymes involved in glycolysis, TCA cycle, and mitochondrial electron transport chain (ETC), and their metabolic intermediates. Absence of stromal-Sparc increased reactive oxygen species and perturbed redox homeostasis. Recombinant SPARC exerted a dose-dependent inhibitory effect on glycolysis, mitochondrial respiration, ATP production and ROS generation. Comparative analysis with human tumors revealed that SPARC-regulated ETC-signature inversely correlated with SPARC transcripts. Targeting mitochondrial ETC by phenformin treatment of tumor-bearing Sparc-deficient and proficient mice mitigated the effect of SPARC-deficiency and significantly reduced tumor burden, ROS, and oxidative tissue damage in syngeneic tumors. In summary, our findings provide novel insights into the role of SPARC in regulating metabolic plasticity and bioenergetics in OvCa, and shines light on its potential therapeutic efficacy.",
keywords = "Glycolysis, Metabolic plasticity, Ovarian cancer, OXPHOS, Peritoneal metastasis, Redox homeostasis, SPARC, Syngeneic model",
author = "Christine Naczki and Bincy John and Chirayu Patel and Ashlyn Lafferty and Alia Ghoneum and Hesham Afify and White, {Michael A} and Amanda Davis and Guangxu Jin and Steven Kridel and Neveen Said",
year = "2018",
month = "10",
day = "16",
doi = "10.3390/cancers10100385",
language = "English (US)",
volume = "10",
journal = "Cancers",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - SPARC inhibits metabolic plasticity in ovarian cancer

AU - Naczki, Christine

AU - John, Bincy

AU - Patel, Chirayu

AU - Lafferty, Ashlyn

AU - Ghoneum, Alia

AU - Afify, Hesham

AU - White, Michael A

AU - Davis, Amanda

AU - Jin, Guangxu

AU - Kridel, Steven

AU - Said, Neveen

PY - 2018/10/16

Y1 - 2018/10/16

N2 - The tropism of ovarian cancer (OvCa) to the peritoneal cavity is implicated in widespread dissemination, suboptimal surgery, and poor prognosis. This tropism is influenced by stromal factors that are not only critical for the oncogenic and metastatic cascades, but also in the modulation of cancer cell metabolic plasticity to fulfill their high energy demands. In this respect, we investigated the role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in metabolic plasticity of OvCa. We used a syngeneic model of OvCa in Sparc-deficient and proficient mice to gain comprehensive insight into the paracrine effect of stromal-SPARC in metabolic programming of OvCa in the peritoneal milieu. Metabolomic and transcriptomic profiling of micro-dissected syngeneic peritoneal tumors revealed that the absence of stromal-Sparc led to significant upregulation of the enzymes involved in glycolysis, TCA cycle, and mitochondrial electron transport chain (ETC), and their metabolic intermediates. Absence of stromal-Sparc increased reactive oxygen species and perturbed redox homeostasis. Recombinant SPARC exerted a dose-dependent inhibitory effect on glycolysis, mitochondrial respiration, ATP production and ROS generation. Comparative analysis with human tumors revealed that SPARC-regulated ETC-signature inversely correlated with SPARC transcripts. Targeting mitochondrial ETC by phenformin treatment of tumor-bearing Sparc-deficient and proficient mice mitigated the effect of SPARC-deficiency and significantly reduced tumor burden, ROS, and oxidative tissue damage in syngeneic tumors. In summary, our findings provide novel insights into the role of SPARC in regulating metabolic plasticity and bioenergetics in OvCa, and shines light on its potential therapeutic efficacy.

AB - The tropism of ovarian cancer (OvCa) to the peritoneal cavity is implicated in widespread dissemination, suboptimal surgery, and poor prognosis. This tropism is influenced by stromal factors that are not only critical for the oncogenic and metastatic cascades, but also in the modulation of cancer cell metabolic plasticity to fulfill their high energy demands. In this respect, we investigated the role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in metabolic plasticity of OvCa. We used a syngeneic model of OvCa in Sparc-deficient and proficient mice to gain comprehensive insight into the paracrine effect of stromal-SPARC in metabolic programming of OvCa in the peritoneal milieu. Metabolomic and transcriptomic profiling of micro-dissected syngeneic peritoneal tumors revealed that the absence of stromal-Sparc led to significant upregulation of the enzymes involved in glycolysis, TCA cycle, and mitochondrial electron transport chain (ETC), and their metabolic intermediates. Absence of stromal-Sparc increased reactive oxygen species and perturbed redox homeostasis. Recombinant SPARC exerted a dose-dependent inhibitory effect on glycolysis, mitochondrial respiration, ATP production and ROS generation. Comparative analysis with human tumors revealed that SPARC-regulated ETC-signature inversely correlated with SPARC transcripts. Targeting mitochondrial ETC by phenformin treatment of tumor-bearing Sparc-deficient and proficient mice mitigated the effect of SPARC-deficiency and significantly reduced tumor burden, ROS, and oxidative tissue damage in syngeneic tumors. In summary, our findings provide novel insights into the role of SPARC in regulating metabolic plasticity and bioenergetics in OvCa, and shines light on its potential therapeutic efficacy.

KW - Glycolysis

KW - Metabolic plasticity

KW - Ovarian cancer

KW - OXPHOS

KW - Peritoneal metastasis

KW - Redox homeostasis

KW - SPARC

KW - Syngeneic model

UR - http://www.scopus.com/inward/record.url?scp=85055489578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055489578&partnerID=8YFLogxK

U2 - 10.3390/cancers10100385

DO - 10.3390/cancers10100385

M3 - Article

C2 - 30332737

AN - SCOPUS:85055489578

VL - 10

JO - Cancers

JF - Cancers

SN - 2072-6694

IS - 10

M1 - 385

ER -